Can truth beat tobacco lies? new study targets disinformation in black adults
NCT ID NCT07543081
First seen Jun 24, 2026 · Last updated Sep 18, 2026 · Updated 3 times
Summary
This study tests whether specially designed anti-disinformation messages can correct false beliefs about the FDA's proposed ban on menthol cigarettes and flavored cigars among Black adults. Researchers will enroll 1,000 Black adults in Atlanta and Birmingham, delivering messages individually and through community campaigns. The goal is to improve knowledge about tobacco industry tactics and flavored tobacco policies, and to increase support for such policies.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Anti-disinformation messaging (behavioral intervention)
- What this could lead to
- If successful, this campaign could help correct harmful disinformation and increase support for flavored tobacco policies in Black communities.
- What could go wrong
- This is an early-stage behavioral study with no direct health outcome; it measures beliefs and intentions, not actual behavior change. Results may not generalize beyond the two cities studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * African American or Black adults * Aged 18+ * U.S citizen or U.S. Legal Permanent Resident * Reside in Atlanta, GA or Birmingham, AL * Able to read and speak English * Willing to engage in all online study activities including online quarterly surveys over a 12-month period * Have access to a digital device, laptop, or desktop with internet access to complete online surveys and watch online videos Exclusion Criteria: * Do not identify as African American or Black * Children aged 17 years and younger * Adults who are not a U.S. Citizen or U.S. Legal Permanent Resident * Do not reside in Atlanta, GA or Birmingham, AL * Do not have access to a digital device, laptop, or desktop with internet access o Unwilling or unable to engage in online study activities
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Disinformation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Rutgers University
New Brunswick, New Jersey, 08901, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.